*|MC_PREVIEW_TEXT|*

DHW Q&A: Micro-Fulfillment, Telehealth, and Crowdfunding With NowRx
October 27, 2021
site logo

Together with

partner logo

“Consumers are pulling the market towards that same-day delivery end state.”

NowRx CEO and Co-Founder Carry Breese

Remote Care

DHW Q&A: Micro-Fulfillment & Telehealth With NowRx

Image Credit: NowRx

With Carry Breese
NowRx, CEO and Co-Founder

At a time when consumers are wary of traveling to crowded pharmacies to pick up their medications, NowRx is taking a new approach to solving medication nonadherence: same-day prescription delivery.

In this Digital Health Wire Q&A we sat down with NowRx CEO Carry Breese to discuss the company’s micro-fulfillment strategy for prescription delivery, recent moves into telehealth, and why equity crowdfunding could be the right fundraising path for many companies.

Can you tell us about NowRx and the company’s overall strategy?

We originally began as a direct-to-consumer pharmacy offering same-day delivery on prescription medication, but as we’ve evolved we’ve begun to look at ourselves more as a digital health platform. We still provide same-day pharmacy delivery, but we also couple that with a broad telehealth platform and virtual services.

The whole key with NowRx is to be a full replacement for traditional pharmacies. To do this, we use a micro-fulfillment strategy, which involves dispensing out of our own brick-and-mortar pharmacies, which are staffed with pharmacists, technicians, and local drivers. The proprietary tech inside our micro-fulfillment centers makes them extremely efficient and keeps costs down.

The philosophy of our company is to use technology to try and fix the bottlenecks in healthcare that produce bad patient experiences.

Earlier this year NowRx moved into telehealth, what was the motivation behind that transition?

The way we built the delivery pharmacy component is probably the best way to illustrate that answer. We’ve always looked at successful approaches to the healthcare industry as needing to integrate as many components as possible to provide a full experience.

Some companies have tried to do delivery pharmacy, but they were mainly just doing delivery logistics, acting as couriers between pharmacies and patients. We felt that model doesn’t give you enough control over what’s going on inside the pharmacy, and can lead to constraints with anything from physician communication to inventory management.

To solve this problem in the best way possible, you need to own the dispensing, have your own software systems, and directly address these constraints.

The entrance into telehealth was an extension of this thinking. Oftentimes it’s not only hard to get a prescription delivered, but also to get an appointment with a physician to write the prescription in the first place. Removing those barriers is key to our mission of providing great healthcare experiences, which is what made telehealth a natural extension for us.

How has the pandemic impacted remote care and your business?

There’s been a few distinct shifts during the pandemic. In the beginning, there was definitely a surge in demand for our services, and at the same time we had to institute all kinds of new safety controls: social distancing in the pharmacies, hygiene for the cars, contactless delivery. This was a huge operational strain, but since then it’s smoothed out quite a bit.

Although there was a significant boost in awareness for new ways to get medication, as well as an increase in demand, doctors began seeing patients less frequently. Patients pulled back on routine checkups and preventative visits, so overall, the pharmacy business saw a bit of a drop off in volume.

We expect that to alleviate as the pandemic wanes, and it’s also likely that we’ll see a strong rebound for new prescriptions driven by the backlog of doctor visits that have been postponed over the past couple of years.

Why did NowRx take a non-traditional approach to crowdfunding its $72 million Series C through SeedInvest and what are the plans for the funding?

Following the heightened demand over the past couple of years, we began looking to broaden our reach without sacrificing quality of service. As NowRx expands into new territories, we first launch a micro-fulfillment location, which requires a large up-front investment. The funding helps cushion that.

We were an early adopter of equity crowdfunding, and this will be our third round through SeedInvest. It works well for NowRx because people can easily grasp the concept. Delivery pharmacy makes a lot of sense to a lot of people.

Crowdfunding allows us to continue focusing on the customer experience while retaining more control over the direction of the company, as opposed to feeling pressure from a VC to grow at all costs. On top of that, it builds brand awareness. The retail investors become engaged ambassadors, even in territories where we don’t currently operate, and they help advocate for NowRx and our mission.

How does NowRx view the competitive landscape and how does it plan to differentiate moving forward?

New entrants like Amazon, especially following the acquisition of PillPack, are cutting the delivery times for medication from around one week down to approximately two days. Our belief is that it’s essential to perfect same-day service. That’s what patients have grown accustomed to in pharmacy. That’s why there’s a pharmacy on every street corner.

Patients have been trained to leave the doctor’s office with a prescription order that they go and get filled later that same day. That’s where our offering is differentiated. The micro-fulfillment strategy allows us to provide highly responsive care, and even one hour delivery, if needed for things like pain medication and antibiotics that are time sensitive.

Consumers are pulling the market towards that same-day delivery end state. That’s why having proprietary software and quick-fill systems to eliminate causes of delay is such a differentiator for the customer experience.

How can remote care be improved and how does NowRx fit into this picture?

The key to success is focusing on improving care and health outcomes above all else. One of the things that people generally don’t think about when they hear “delivery pharmacy” is how it helps to solve the problem of people not taking their medications.

Medication nonadherence is a huge strain on the health system, and it has many different causes. A majority of the time, it’s due to one of three reasons. The first is time and inconvenience. The second is lack of transportation. The third is simply “forgetting” to pick up a prescription. NowRx addresses all three of these directly.

There are countless unnecessary hospitalizations and avoidable issues due to medication nonadherence, so that’s one of the biggest problems we’re trying to solve. There’s so much inefficiency in the healthcare system, and we’re excited about using new technology and delivery models to address it.

facebook twitter linkedin read story online

Explore Nuance’s Personalized Patient Experience

Personalized digital experiences drive better outcomes for patients and providers. Explore how Nuance is using AI automation to advance the quality of service across the care journey here.

sponsor logo

The Wire

  • Machine Learning Fairness: A Carnegie Mellon University study published in Nature found that “fairness” can be achieved in machine learning models without significant tradeoffs in accuracy or model complexity. While evaluating an AI system that predicts mental health needs for inmates, a simplified model architecture led to more equitable results than a composite model approach that was more likely to overfit the data. The researchers point out that fairness must be a priority during any AI implementation, ensuring that model designs and data labels are specifically chosen to avoid bias.
  • Cigna Virtual Care: Cigna announced that it is expanding access to covered telehealth services and launching a virtual-first health plan to select employers through MDLIVE, a virtual care company acquired by Cigna subsidiary Evernorth earlier this year. The plan includes comprehensive primary care with no copay for MDLIVE providers, making Cigna the latest payor to expand into telehealth-led services following similar moves from UnitedHealthcare and Aetna.
  • Patina Series A: Senior-focused healthcare provider Patina emerged from stealth, announcing a $50m Series A round. Patina’s hybrid primary care model involves both in-person and virtual care teams that build longitudinal relationships with older adults, supporting their unique physical and emotional needs so that they can live healthier lives while maintaining independence.
  • Intervention + Coaching: The Omada Insights Lab released its first report on users of its chronic care management programs, finding that users who engaged with health coaches in the first week are 94% more likely to achieve desired outcomes, while members of its weight management program who messaged their coach experienced twice the weight loss as members who didn’t. These results echo the findings of a recent Hello Heart study that found that coaching combined with an intervention is significantly more effective than either component individually.
  • Bayer’s 2021 G4As: Bayer’s G4A Digital Health Partnerships program added five new “Advance Track” digital health startups, including: Cordio Medical (voice-enabled congestive heart failure detection), Liva Healthcare (behavior change coaching), Woebot Health (chat bot therapy), Nines (AI-enabled teleradiology), and Zed Technologies (medical image sharing). The new startups follow over 50 Advance Track alumni, which have gone on to raise a combined $998m.
  • One Drop CVD: Outside of its G4A portfolio, Bayer is making digital health headlines through its partnership with chronic condition management company One Drop, which announced the release of its cardiovascular disease (CVD) prevention module. The new CVD module provides users with connected devices to capture blood pressure and weight measurements that are then automatically uploaded to the One Drop app. The app gives users access to one-on-one coaching from RNs and AI-enabled predictions to better manage their blood pressure.
  • Patient Engagement Apps: A new study in Telemedicine and e-Health investigated 54 mHealth apps to determine which components of app design encouraged or hindered engagement. Common app components associated with increased engagement included: personalized content, data visualization, self-monitoring features, and goal-setting functionality. Researchers also provided future app developers with components to avoid when building for engagement, including: social forums, poor app navigation, and technical difficulties.
  • Click Therapeutics Funding: Digital therapeutics platform Click Therapeutics closed $52m in Series B financing that it will use to develop its virtual solutions for conditions ranging from psychiatry and chronic pain to cardiometabolic and autoimmune disorders. The company also began collaborating with Otsuka to develop and commercialize a prescription digital therapeutic for depression, and is working with Boehringer Ingelheim to create a prescription-based virtual aid for schizophrenics.
  • The Case for LCS Telehealth: A new American College of Surgeons study suggests that virtual lung cancer screening consultations should remain a viable option after the pandemic, and could be valuable for other cancer screenings. Temple University Hospital previously held CT LCS exams and consultations during the same on-site visit, but made the consultations virtual during the pandemic. Analysis of the two periods (n = 637 & 440) revealed that the on-site and virtual visits had similar diagnostic results and follow-up recommendations, and didn’t adversely affect African American patients.
  • Amazon Smart Property: Amazon is adding new functionality to its Alexa Smart Property solution designed to make it easier to deploy and manage its smart devices at scale. The new features make the Alexa voice assistant more effective within hospitals and senior living communities, allowing users to easily connect with care teams and family, view and create schedules, and control other devices in their room.